MAGEA1 and hTERT Peptide Treatment Improves the Potency of The Dendritic Cell- Cytotoxic T Lymphocytes (DC-CTL) Immunotherapy in DAC Treated Acute Myeloid Leukemia

Background: Acute myeloid leukemia (AML) is a type of heterogenous malignant hematological disorder. Recently developed immunotherapies such as chimeric antigen receptor T cell (CAR-T) do not demonstrated promising therapeutic results due to the off-target effect. The Dendritic cell-cytotoxic T lymp...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Guocheng, Zhao, Weiqiang, Li, Yisheng, Jin, Guangyi, Zeng, Wei, Yu, Changhua, Zhou, Ji, Yu, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899371/
https://www.ncbi.nlm.nih.gov/pubmed/35281868
http://dx.doi.org/10.7150/jca.66501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899371/
https://www.ncbi.nlm.nih.gov/pubmed/35281868
http://dx.doi.org/10.7150/jca.66501

Ejemplares similares